Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Formulation development during

For the intramolecular variant, synthetically valuable applications have been developed during the last decade." " Three types of intramolecular ene reactions are formulated—depending on the structure of the starting material ... [Pg.105]

The final physical properties of thermoset polymers depend primarily on the network structure that is developed during cure. Development of improved thermosets has been hampered by the lack of quantitative relationships between polymer variables and final physical properties. The development of a mathematical relationship between formulation and final cure properties is a formidable task requiring detailed characterization of the polymer components, an understanding of the cure chemistry and a model of the cure kinetics, determination of cure process variables (air temperature, heat transfer etc.), a relationship between cure chemistry and network structure, and the existence of a network structure parameter that correlates with physical properties. The lack of availability of easy-to-use network structure models which are applicable to the complex crosslinking systems typical of "real-world" thermosets makes it difficult to develop such correlations. [Pg.190]

A major development in pharmaceutical technology has been the application of instrumentation techniques to tablet presses. The ability to monitor the forces that develop during the compaction, ejection, and detachment of tablets has brought about new insights into the physics of compaction, facilitated formulation development, and provided a means for the in-process control of tablet weight in manufacturing [62,63], In... [Pg.356]

Because membrane filtration is the only currently acceptable method of sterilizing protein pharmaceuticals, the adsorption and inactivation of proteins on membranes is of particular concern during formulation development. Pitt [56] examined nonspecific protein binding of polymeric microporous membranes typically used in sterilization by membrane filtration. Nitrocellulose and nylon membranes had extremely high protein adsorption, followed by polysulfone, cellulose diacetate, and hydrophilic polyvinylidene fluoride membranes. In a subsequent study by Truskey et al. [46], protein conformational changes after filtration were observed by CD spectroscopy, particularly with nylon and polysulfone membrane filters. The conformational changes were related to the tendency of the membrane to adsorb the protein, although the precise mechanism was unclear. [Pg.703]

The primary method for demonstration of the existence of drug polymorphs, or solvate species, is that of powder x-ray diffraction (XRD). Such measurements represent a specification of the internal structure within a crystal, and an evaluation of its lattice type. Since dissolution and subsequent drying can sometimes yield an undesired structure, it is also important to confirm crystal structures at each formulation stage during the beginning of the development process. [Pg.15]

Thermal methods can be extremely useful during the course of preformulation studies, since carefully planned work can be used to indicate the existence of possible drug-excipient interactions in a prototype formulation [2]. During the course of this aspect of drug development, thermal methods can be used to evaluate compound purity, polymorphism, solvation, degradation, drug-excipient compatibility, and a wide variety of other desirable characteristics. Several recent reviews have been written on such investigations [2-6]. [Pg.224]

The fed and fasted state may also have significant effects on the absorption or solubility of a compound. Compositions of media that simulate the fed and fasted states can be found in the literature (19) (see also Chapter 5). These media reflect changes in the pH, bile concentrations, and osmolarity after meal intake and therefore have a different composition than that of typical compendial media. They are primarily used to establish in vitro-in vivo correlations during formulation development and to assess potential food effects and are not intended for quality control purposes. For quality control purposes, the substitution of natural surfactants (bile components) with appropriate synthetic surfactants is permitted and encouraged because of the expense of the natural substances and the labor-intensive preparation of the biorelevant media. [Pg.360]

So-called infinity points can be useful during development studies. To obtain an infinity point, the paddle or basket speed is increased significantly (e.g., 150 rpm) at the end of the run and the test is allowed to run for an extended period of time (e.g., 60 min), and then an additional sample is taken. Although there is no requirement for 100% dissolution in the profile, the infinity point can provide data that may provide useful information about the formulation characteristics during the initial development. [Pg.364]

We can recognize four main periods in the history of the study of aqueous solutions. Each period starts with one or more basic discoveries or advances in theoretical understanding. The first period, from about 1800 to 1890, was triggered by the discovery of the electrolysis of water followed by the investigation of other electrolysis reactions and electrochemical cells. Developments during this period are associated with names such as Davy, Faraday, Gay-Lussac, Hittorf, Ostwald, and Kohlrausch. The distinction between electrolytes and nonelectrolytes was made, the laws of electrolysis were quantitatively formulated, the electrical conductivity of electrolyte solutions was studied, and the concept of independent ions in solutions was proposed. [Pg.467]

Simmons, D. M., Gierer, D. S. A material sparing test to predict punch sticking during formulation development. Drug Dev. Ind. Pharm., 38(9), 2012, 1054-1060. [Pg.44]

Chen, B.L.,T. Arakawa, E. Hsu, L.O. Narhi, T.J. Tressel, and S.L. Chien, Strategies to suppress aggregation of recombinant keratinocyte growth factor during liquid formulation development. J Pharm Sci, 1994. 83(12) 1657-61. [Pg.124]


See other pages where Formulation development during is mentioned: [Pg.585]    [Pg.616]    [Pg.372]    [Pg.169]    [Pg.702]    [Pg.704]    [Pg.706]    [Pg.710]    [Pg.712]    [Pg.487]    [Pg.98]    [Pg.26]    [Pg.989]    [Pg.252]    [Pg.283]    [Pg.302]    [Pg.320]    [Pg.351]    [Pg.355]    [Pg.16]    [Pg.45]    [Pg.10]    [Pg.147]    [Pg.529]    [Pg.533]    [Pg.540]    [Pg.574]    [Pg.413]    [Pg.75]    [Pg.232]    [Pg.258]    [Pg.61]    [Pg.166]    [Pg.184]    [Pg.989]    [Pg.25]    [Pg.268]    [Pg.157]    [Pg.286]   
See also in sourсe #XX -- [ Pg.681 ]




SEARCH



Drug formulation development optimized during

During development

Formulation development

© 2024 chempedia.info